<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04008329</url>
  </required_header>
  <id_info>
    <org_study_id>MRCTA,ECFAH of FMU [2019]191</org_study_id>
    <nct_id>NCT04008329</nct_id>
  </id_info>
  <brief_title>A Registered Cohort Study on Amyotrophic Lateral Sclerosis</brief_title>
  <official_title>A Registered Cohort Study on Amyotrophic Lateral Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Fujian Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Fujian Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Amyotrophic lateral sclerosis (ALS) is a kind of motor neuron degeneration disorder without
      effective therapy. This registered cohort study will provide further insights into the
      clinical course of ALS, and investigate disease-relative risk factors and the genetic
      background of Chinese ALS patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND),
      which is characterized with highly clinical heterogeneity and no effective treatment is
      available now. The purpose of this registered cohort is to observe the natural history of ALS
      patients in China, and then identify some factors correlated with disease progression.
      Besides, ALS-related gene mutations will be screened and explore novel disease causing gene
      as well.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2019</start_date>
  <completion_date type="Anticipated">July 2059</completion_date>
  <primary_completion_date type="Anticipated">July 2029</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Age at death</measure>
    <time_frame>10 years</time_frame>
    <description>the time when patient die</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Age of endotracheal intubation or tracheotomy</measure>
    <time_frame>10 years</time_frame>
    <description>the time for the patient accepted endotracheal intubation or tracheotomy</description>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        ALS patients who are diagnosed in the First Affiliated Hospital of Fujian Medical
        University
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Amyotrophic Lateral Sclerosis patients fulfilling the El Escorial criteria (including
             definite, probable and possible)

          -  Progressive muscular atrophy

          -  Primary lateral sclerosis

          -  Progressive bulbar palsy

        Exclusion Criteria:

          -  History of serious head trauma or neuropsychiatric disease

          -  Decline to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ning Wang, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Fujian Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Qi-Jie Zhang, PhD</last_name>
    <phone>086-591-87982772</phone>
    <email>qijiezhang86@fjmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neurology, First Affiliated Hospital of Fujian Medical University</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350005</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qi-Jie Zhang, PhD</last_name>
      <phone>086-591-87982772</phone>
      <email>qijiezhang86@fjmu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Ning Wang, PhD</last_name>
      <phone>086-591-87982772</phone>
      <email>nwang900@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ning Wang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wan-Jian Chen</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 1, 2019</study_first_submitted>
  <study_first_submitted_qc>July 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>July 6, 2019</last_update_submitted>
  <last_update_submitted_qc>July 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Fujian Medical University</investigator_affiliation>
    <investigator_full_name>Ning Wang, MD., PhD.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>amyotrophic lateral sclerosis</keyword>
  <keyword>natural history</keyword>
  <keyword>genetics</keyword>
  <keyword>prognostic factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

